SSY Group Ltd
Mr. Feng Hao is a non-executive director. He is also currently serves as a deputy general manager and the secretary to the board of directors of Sichuan Kelun Pharmaceutical Co., Ltd. (“Sichuan Kelun”). Mr. Feng has a Master’s degree; was a teacher at the School of Economics at Huazhong University of Science and Technology; an analyst at the Actuarial Division of Taiping Life Insurance Company Limited; an actuarial advisory consultant at Watson Wyatt Consultancy (Shanghai) Ltd.; a senior manager at the investment banking division of Ping An Securities Limited; and a business director at the investment banking division of Sinolink Securities Co. Ltd. Since April 2014, Mr. Feng has been a deputy general manager and the secretary to the board of directors of Sichuan Kelun.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
SSY Group Ltd
SSY Group Limited is an investment holding company principally engaged in the research, development, manufacture and sale of pharmaceutical products. Its products include finished medicines of intravenous infusion solution for hospitals and distributors, bulk pharmaceuticals and medical materials. The Company's subsidiaries include New Orient Investments Pharmaceutical Holding (Hong Kong) Limited, Shijiazhuang No.4 Pharmaceutical Co., Ltd. and Hebei Guolong Pharmaceutical Co., Ltd. Through its subsidiaries, the Company is also engaged in logistics of pharmaceutical products in Mainland China.